These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31559459)

  • 1. Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.
    Nagano N; Yano T; Fujita Y; Kouzu H; Koyama M; Ikeda H; Yasui K; Muranaka A; Nishikawa R; Takahashi R; Kishiue N; Yuda S; Miura T
    Heart Vessels; 2020 Apr; 35(4):521-530. PubMed ID: 31559459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
    Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis.
    Guazzi M; Bandera F; Pelissero G; Castelvecchio S; Menicanti L; Ghio S; Temporelli PL; Arena R
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1373-81. PubMed ID: 23997100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide.
    Watanabe T; Iwai-Takano M; Oikawa M; Yamaki T; Yaoita H; Maruyama Y
    J Am Soc Echocardiogr; 2008 Jun; 21(6):689-96. PubMed ID: 17904810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right atrial volume index in chronic systolic heart failure and prognosis.
    Sallach JA; Tang WH; Borowski AG; Tong W; Porter T; Martin MG; Jasper SE; Shrestha K; Troughton RW; Klein AL
    JACC Cardiovasc Imaging; 2009 May; 2(5):527-34. PubMed ID: 19442936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired right ventricular function as a predictor of early mortality in patients with light‑ chain cardiac amyloidosis assessed in a cardiology department.
    Szczygieł JA; Wieczorek PZ; Drozd-Sokołowska J; Michałek P; Mazurkiewicz Ł; Legatowicz-Koprowska M; Walczak E; Jędrzejczak WW; Dwilewicz-Trojaczek J; Grzybowski J
    Pol Arch Intern Med; 2017 Dec; 127(12):854-864. PubMed ID: 29112180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new staging system using right atrial strain in patients with immunoglobulin light-chain cardiac amyloidosis.
    Usuku H; Yamamoto E; Sueta D; Shinriki R; Oike F; Tabata N; Ishii M; Hanatani S; Hoshiyama T; Kanazawa H; Arima Y; Takashio S; Kawano Y; Oda S; Kawano H; Ueda M; Tsujita K
    ESC Heart Fail; 2024 Jun; 11(3):1612-1624. PubMed ID: 38400613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
    Kimishima Y; Yoshihisa A; Kiko T; Yokokawa T; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Takeishi Y
    Int Heart J; 2019 Sep; 60(5):1106-1112. PubMed ID: 31484874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis.
    Aljama MA; Sidiqi MH; Dispenzieri A; Gertz MA; Lacy MQ; Buadi FK; Dingli D; Muchtar E; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Warsame RM; Kourelis T; Hwa YL; Kapoor P; Leung N; Go RS; Kyle RA; Rajkumar SV; Kumar SK
    Blood Adv; 2019 Apr; 3(8):1226-1229. PubMed ID: 30975646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Sze S; Pellicori P; Zhang J; Clark AL
    Heart; 2019 Feb; 105(4):297-306. PubMed ID: 30121635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?
    Pellicori P; Kallvikbacka-Bennett A; Khaleva O; Carubelli V; Costanzo P; Castiello T; Wong K; Zhang J; Cleland JG; Clark AL
    Int J Cardiovasc Imaging; 2014 Jan; 30(1):69-79. PubMed ID: 24150723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
    Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM
    Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis.
    Zhao L; Li J; Tian Z; Fang Q
    J Cardiol; 2016 Nov; 68(5):426-430. PubMed ID: 26685729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.
    Mottram PM; Leano R; Marwick TH
    Am J Cardiol; 2003 Dec; 92(12):1434-8. PubMed ID: 14675580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.
    Salinaro F; Meier-Ewert HK; Miller EJ; Pandey S; Sanchorawala V; Berk JL; Seldin DC; Ruberg FL
    Eur Heart J Cardiovasc Imaging; 2017 Sep; 18(9):1057-1064. PubMed ID: 27965280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.